Kinetics of plasma osteopontin during treatment in patients with pulmonary tuberculosis. A preliminary study

B. Grigoriu, B. Moldoveanu, M. Enache, D. Simion, S. Arama, D. Gramada (Iasi, Romania)

Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment
Session: New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment
Session type: E-Communication Session
Number: 2852
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Grigoriu, B. Moldoveanu, M. Enache, D. Simion, S. Arama, D. Gramada (Iasi, Romania). Kinetics of plasma osteopontin during treatment in patients with pulmonary tuberculosis. A preliminary study. Eur Respir J 2008; 32: Suppl. 52, 2852

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Study of states of leukocytes in blood of pulmonary tuberculosis patients with different efficacy of treatment.
Source: Virtual Congress 2020 – Tuberculosis and society
Year: 2020


A comparative study on serum ADA levels in cavitary and non-cavitary pulmonary tuberculosis patients
Source: Eur Respir J 2003; 22: Suppl. 45, 160s
Year: 2003

Comparison of serum CA-125 levels in pulmonary tuberculosis, pleural tuberculosis and treated active pulmonary tuberculosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 453s
Year: 2005

A randomized study of bronchoscopic blockade of the affected part of a lung as a part the complex treatment of patients with drug-resistant pulmonary tuberculosis
Source: Annual Congress 2012 - Tuberculosis: invasive diagnostic and therapeutic interventions
Year: 2012

Hemodynamics and response to therapy of pulmonary hypertension in patients with interstitial lung disease: Preliminary results of the "HYPID" prospective study
Source: Annual Congress 2012 - Pulmonary circulation: clinical treatment
Year: 2012

VEGF serum levels in COPD patients without pulmonary hypertension – a case control study
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018

Enhanced clinical improvement in pulmonary tuberculosis patients with antioxidant supplementation: a preliminary report
Source: Eur Respir J 2003; 22: Suppl. 45, 40s
Year: 2003

Evaluation of D-dimer levels in patients with active pulmonary tuberculosis and latent tuberculosis infection
Source: Eur Respir J 2006; 28: Suppl. 50, 164s
Year: 2006

Relation between level of acute phase proteins and efficiency of treatment in patients with pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 8s
Year: 2006

Evaluation of sICAM-1 as a serum marker for follow-up of pulmonary tuberculosis therapy
Source: Eur Respir J 2005; 26: Suppl. 49, 454s
Year: 2005

The efficacy of treatment with surfactant-BL (S-BL) in patients with destructive pulmonary tuberculosis
Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis
Year: 2007


The effect of smoking on the treatment outcome in patients with pulmonary tuberculosis: A prospective cohort study
Source: Annual Congress 2011 - Clinical tuberculosis
Year: 2011


Treatment results in patients with drug resistant pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 612s
Year: 2002

High serum periostin levels and the association with pulmonary tuberculosis
Source: International Congress 2018 – Diagnosis of tuberculosis
Year: 2018

A pilot study of recombinant interferon-γ in the treatment of chronic refractory sarcoidosis (preliminary results)
Source: Eur Respir J 2003; 22: Suppl. 45, 234s
Year: 2003

Serum concentration of cytokines before and during treatment in patients with active tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 10s
Year: 2002

Levels of IL-1β and TNFα production in patients with lung tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 315s
Year: 2002

Comparison of the serum soluble IL-2 receptor levels in the differential diagnosis of pulmonary tuberculosis and lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 475s
Year: 2001

Late Breaking Abstract - Correlation of sputum microRNA-144 expression levels with treatment response among pulmonary tuberculosis patients
Source: International Congress 2018 – New developments in tuberculosis
Year: 2018



Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registry
Source: Eur Respir J, 56 (2) 1902279; 10.1183/13993003.02279-2019
Year: 2020